Insulet Corporation (FRA:GOV)

Market Cap	14.45B -24.6%
Revenue (ttm)	2.31B +30.7%
Net Income	210.46M -40.9%
EPS	2.96 -39.9%
Shares Out	n/a
PE Ratio	68.68
Forward PE	38.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	15
Open	211.00
Previous Close	211.10
Day's Range	203.70 - 211.00
52-Week Range	201.50 - 304.00
Beta	n/a
RSI	38.83
Earnings Date	Feb 18, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controll...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GOV

Financial Performance

In 2025, Insulet's revenue was $2.71 billion, an increase of 30.73% compared to the previous year's $2.07 billion. Earnings were $247.10 million, a decrease of -40.93%.

Financial numbers in USD